Related Experiment Video
Updated: Jun 6, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Antiglycine-receptor encephalomyelitis with rigidity
Natalia Mas1, Albert Saiz, Maria Isabel Leite
1Service of Neurology, Hospital Clínic and Institut d' Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Background:
Glycine receptor antibodies (GlyR-ab) were reported in a patient with progressive encephalomyelitis with rigidity and myoclonus (PERM).
Methods:
Three additional patients were clinically described. GlyR-ab was detected with a cell-based assay of HEK293 cells transfected with the α1 subunit of the GyR.
Results:
A 33-year-old woman presented with diplopia, dysphagia and gait ataxia that improved in 5 weeks. Then, she developed a typical stiff-person syndrome (SPS) that resolved with corticosteroids, but relapsed 17 months later with a stiff limb syndrome. After treatment with intravenous immunoglobulins (IVIG), she has been asymptomatic for 8 years. A 60-year-old man developed, dysphagia, diplopia, left facial palsy and right trigeminal hypoaesthesia in a few days, followed by muscular rigidity, corticospinal signs, myoclonic jerks and severe dysautonomia. He developed seizures and suffered a cardiac arrest that left him in a persistent vegetative state. A 48-year-old man presented with leg rigidity and frequent spells of trismus, muscle spasms followed by opisthotonus and diaphoresis. The symptoms were antedated by pruritus of the left scapulae, right arm and T11-T12 dermatome. At the same time he became progressively more aggressive with emotional irritability. He also developed dysgeusia (metallic taste) and severe concurrent behavioural changes and diurnal hypersomnia. Only the rigidity and the spasms improved after therapy.
Conclusions:
The clinical picture associated with GlyR-ab is wider than the classical view of PERM. GlyR-ab should be examined in patients with core symptoms of muscle rigidity and spasms atypical for SPS.
Insights
Glycine receptor antibodies (GlyR-ab) are associated with a broader spectrum of neurological disorders than previously thought. Testing for GlyR-ab is recommended for patients presenting with muscle rigidity and spasms not typical of stiff-person syndrome (SPS).
Area of Science:
- Neuroimmunology
- Neurology
- Autoimmune Encephalitis
Background:
- Glycine receptor antibodies (GlyR-ab) have been previously identified in patients with progressive encephalomyelitis with rigidity and myoclonus (PERM).
- This study investigates additional patients with GlyR-ab to further delineate the clinical spectrum associated with these antibodies.
Observation:
- Three patients with GlyR-ab presented with diverse neurological symptoms including diplopia, dysphagia, gait ataxia, facial palsy, trigeminal hypoaesthesia, and autonomic dysfunction.
- Clinical manifestations ranged from stiff-person syndrome (SPS) and stiff limb syndrome to severe encephalopathy with seizures and cardiac arrest.
- One patient experienced behavioral changes, emotional irritability, and sensory disturbances preceding motor symptoms.
Findings:
- GlyR-ab were detected using a cell-based assay involving HEK293 cells transfected with the GlyR α1 subunit.
- The clinical presentations in these patients extended beyond the classical PERM, encompassing features overlapping with SPS and other autoimmune neurological disorders.
- Treatment responses varied, with corticosteroids and intravenous immunoglobulins (IVIG) showing partial or complete symptom resolution in some cases.
Implications:
- The clinical spectrum associated with GlyR-ab is broader than the classical view of PERM, suggesting GlyR-ab as a potential biomarker for a wider range of autoimmune neurological conditions.
- GlyR-ab testing should be considered in patients presenting with core symptoms of muscle rigidity and spasms, especially when the presentation is atypical for SPS.
- Early identification and targeted immunotherapy may improve outcomes for patients with GlyR-ab associated neurological disorders.
More Related Videos
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Rabies
Antiepileptic Drugs: Glutamate Antagonists
Alterations in Muscle Tone lll